<DOC>
	<DOCNO>NCT01606826</DOCNO>
	<brief_summary>The mission SARP improve understand severe asthma integrate study clinical biological feature evaluate change time . The ultimate goal effort promote good treatment severe asthma .</brief_summary>
	<brief_title>Severe Asthma Research Program</brief_title>
	<detailed_description>The mission SARP improve understand severe asthma develop good treatment . The SARP gain well understanding asthma endotypes , child adult , define disease molecular cellular level context temporal phenotypic expression disease . To end , SARP investigator utilize mechanistic evoke phenotype approach : 1 ) characterize developmental molecular , cellular physiologic phenotype child adult mild severe asthma , 2 ) elucidate evolve pathobiology pathogenesis severe asthma sub-phenotypes 3 ) compare feature time . This approach involve share longitudinal protocol conduct across participate center include common information SARP participant . Additionally , SARP investigator identify mechanistic research question include shared longitudinal protocol . Together , longitudinal mechanistic approach enable prediction phenotype stability/fluctuation pharmacologic responses identification novel , disease-modifying target treatment .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Asthmatic Patients : 1 . Physician diagnosis asthma , 2 . Age 6 year old 3 . Evidence historical reversibility , include either : FEV1 bronchodilator reversibility ≥ 12 % , Airway hyperresponsiveness reflect methacholine PC20 ≤16 mg/mL . 1 . Pregnancy characterization phase , 2 . Current smoking , 3 . Smoking history &gt; 10 pack year ≥30 year age , smoke history &gt; 5 pack year &lt; 30 year age ( Note : subject smoke history , smoke within past year ) , 4 . Other chronic pulmonary disorder associate asthmalike symptom , include ( limited ) cystic fibrosis , chronic obstructive pulmonary disease , chronic bronchitis , vocal cord dysfunction ( sole cause respiratory symptom PI 's discretion ) , severe scoliosis chest wall deformity affect lung function , congenital disorder lung airway , 5 . History premature birth 35 week gestation , 6 . Unwillingness receive intramuscular triamcinolone acetonide injection , 7 . Evidence participant family may unreliable poorly adherent asthma treatment study procedure , 8 . Planning relocate clinical center area study completion , 9 . Any criteria place subject unnecessary risk accord judgment Principal Investigator and/or attend physician ( ) record , 10 . Currently participate investigational drug trial asthma therapy . Healthy Controls : Inclusion criterion : Healthy subject age 18 65 year . At least 3 7 subject per center age 35 year old . Exclusion criteria 1 . History chronic disease affect lung , 2 . A history suggestive allergic rhinitis , eczema chronic sinusitis , 3 . An improvement FEV1 12 % follow 4 puff albuterol , 4 . Smoking history &gt; 10 pack year ≥30 year age , smoke history &gt; 5 pack year &lt; 30 year age , smoke within past year , 5 . Respiratory tract infection within past 4 week , 6 . Pregnancy , 7 . History premature birth ( &lt; 35 week ) .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Severe</keyword>
</DOC>